ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

Grants Funding; NCI Restores Paylines To Last Year’s Levels

July 4, 1997

Bush Administration proposes 2.7 percent increase for NIH in fiscal year 2005; NIH budgets listed by institute.

February 6, 2004

Tucson Conference Could Be Lively

February 16, 1979

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984